| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 13 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-03-02 |
4 |
B |
$24.84 |
$372,600 |
I/I |
15,000 |
1,530,323 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-14 |
4 |
A |
$12.86 |
$192,900 |
I/I |
15,000 |
1,814,423 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-21 |
4 |
S |
$2.10 |
$32,642 |
I/I |
(15,566) |
10,938,689 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-20 |
4 |
B |
$16.48 |
$260,577 |
D/D |
15,815 |
3,271,465 |
2.39 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-06-13 |
4 |
B |
$13.70 |
$218,748 |
I/I |
15,967 |
12,088,125 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-08 |
4 |
B |
$3.80 |
$60,754 |
D/D |
16,000 |
3,620,772 |
2.45 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-11-09 |
5 |
GD |
$0.00 |
$0 |
I/I |
16,300 |
29,340 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-11-09 |
5 |
GA |
$0.00 |
$0 |
I/I |
16,300 |
383,610 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2017-12-12 |
4 |
D |
$40.01 |
$653,043 |
D/D |
(16,322) |
3,369,053 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-12 |
4 |
S |
$2.65 |
$44,238 |
I/I |
(16,667) |
598,345 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-15 |
4 |
B |
$4.38 |
$74,679 |
I/I |
17,050 |
18,301,963 |
2.25 |
% |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,310 |
1,812,246 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-12-06 |
4 |
OE |
$32.88 |
$706,387 |
D/D |
18,172 |
1,899,203 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-12-07 |
4 |
S |
$77.78 |
$1,413,451 |
D/D |
(18,172) |
1,875,193 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-14 |
4 |
S |
$1.89 |
$34,383 |
I/I |
(18,192) |
646,418 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-12 |
4 |
B |
$3.74 |
$69,293 |
D/D |
18,518 |
3,718,779 |
2.45 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2013-12-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
18,630 |
701,549 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-05-21 |
4 |
A |
$19.02 |
$367,086 |
I/I |
19,300 |
2,043,723 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-09 |
4 |
A |
$14.37 |
$280,215 |
I/I |
19,500 |
1,630,423 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-07-27 |
4 |
S |
$0.86 |
$17,074 |
I/I |
(19,748) |
4,065,044 |
0 |
% |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2003-12-12 |
4 |
A |
$7.81 |
$185,250 |
D/D |
19,752 |
1,395,209 |
|
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-07-16 |
4 |
B |
$19.89 |
$397,800 |
I/I |
20,000 |
10,678,690 |
2.25 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
10% Owner |
– – • |
2015-07-28 |
4 |
B |
$15.00 |
$300,000 |
I/I |
20,000 |
1,279,903 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-02 |
4 |
B |
$13.46 |
$269,200 |
I/I |
20,000 |
11,268,178 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-08 |
4 |
B |
$12.32 |
$246,400 |
I/I |
20,000 |
11,355,586 |
2.25 |
- |
|
634 Records found
|
|
Page 13 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
